SIMBHALS.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: January 06, 2025
Report Source: 2025 2nd Quarter Report
Simbhaoli Sugars Ltd. Stock Analysis SIMBHALS.NS
Simbhaoli Sugars Ltd. engages in the production and marketing of sugar and alcohol as well as power generation. The company is headquartered in Noida, Uttar Pradesh. The firm is technology driven with a business mix that spans from refined (sulphur less) sugar, specialty sugars, extra neutral alcohol (ENA), ethanol, sanitizer, and bio-manure. The company is engaged in sugar refining (Defeco Remelt Phosphotation and Ion Exchange technology), niche products (specialty sugars), and clean energy (ethanol). The firm sells international standard refined, pharmaceutical grade and specialty sugars to the retail and bulk institutional consumer segments. The Company’s segments include Sugar and Alcohol. The firm operates its businesses through subsidiaries, such as Simbhaoli Power Private Limited (SPPL), Integrated Casetech Consultants Private Limited (ICCPL), and Simbhaoli Speciality Sugars Private Limited (SSSPL). The firm has three sugar complexes in Simbhaoli (Western Uttar Pradesh), Chilwaria (Eastern Uttar Pradesh), and Brijnathpur (Western Uttar Pradesh).
Read More Simbhaoli Sugars Ltd (SIMBHALS.NS) Chart
Key Statistics of Simbhaoli Sugars Ltd (SIMBHALS.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹9.28Volume
111.00P/E Ratio (TTM)
1.5652 Week Range
Market Cap
393.39MAvg. Volume
19.11KDividend Yield
-Financial Metrics & Statements of Simbhaoli Sugars Ltd (SIMBHALS.NS)
FAQ's for Simbhaoli Sugars Ltd (SIMBHALS.NS)
- According to Musaffa’s Shariah screening methodology, Simbhaoli Sugars Ltd (SIMBHALS.NS) is currently classified as NOT HALAL as of January 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.